Asad Haider

Stock Analyst at Goldman Sachs

(0.8)
# 2447
Out of 5,441 analysts
7
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
NAMS NewAmsterdam Pharma ...
Initiates Coverage On: Neutral
27
24.4 10.66% 1 Jul 17, 2025
BNTX BioNTech
Initiates Coverage On: Neutral
110
109.29 0.65% 1 May 29, 2025
JNJ Johnson & Johnson
Upgrades: Buy
157 172
173.87 -1.08% 1 Apr 9, 2025
LLY Eli Lilly
Upgrades: Buy
892 888
635.48 39.74% 1 Apr 8, 2025
ABBV AbbVie
Assumes: Neutral
194
198.62 -2.33% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 25
24.61 1.58% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
67 55
45.94 19.72% 1 Apr 8, 2025